Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ankon Medical Technologies is a leading medical device company focused on the development of robotic capsule endoscopy systems for gastrointestinal diagnostics. The company's flagship product, the NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) system, enables a non-invasive and painless examination of the stomach, providing a patient-friendly alternative to traditional gastroscopy. By utilizing advanced magnetic control technology and artificial intelligence, Ankon's platform allows physicians to navigate the capsule with high precision to detect lesions and early-stage cancers. Headquartered in Shanghai, the company has expanded its reach globally, securing regulatory approvals in multiple jurisdictions including China and the United States. Ankon continues to innovate in the field of digital health by integrating AI-assisted diagnostic tools into its endoscopy platform to improve clinical efficiency and accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ankon Medical Technologies.